Pro zobrazení tohoto obsahu je třeba být přihlášen.
Author Archives for m.popovic@wemakemedia.cz
Adjuvant Docetaxel Fails to Improve DFS for Intermediate- or High-Risk Prostate Cancer
23 septembra, 2020 4:51 pm Leave your thoughtsJune 14, 2018 Treatment with docetaxel without prednisone failed to improve biochemical disease-free survival (DFS) compared with surveillance in...
SPRÁVA Z VÝROČNEJ KONFERENCIE AMERICKEJ ONKOLOGICKEJ SPOLOČNOSTI 2018
23 septembra, 2020 4:51 pm Leave your thoughtsV dňoch 1. – 5. júna 2018 sa v americkom Chicagu uskutočnila výročná konferencia Americkej onkologickej spoločnosti (ASCO). Prezentované boli mnohé zaujímavé...
Adjuvant chemotherapy for pathological stage I non-small cell lung cancer with high-risk factors for recurrence: A multicenter study
18 septembra, 2020 8:01 pm Leave your thoughtsAuthors: Yasuhiro Tsutani, Kentaro Imai, Hiroyuki Ito, et. al. Abstract: 8500 Citation: J Clin Oncol 37, 2019 (suppl;...
Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3)
18 septembra, 2020 8:01 pm Leave your thoughtsAuthors: David J. Kwiatkowski, Valerie W. Rusch, Jamie E. Chaft, et. al. Abstract: 8503 Clinical Trial Registry Number:...
Preliminary results of single arm phase 2 trial of brigatinib in patients (pts) with progression disease (PD) after next-generation (NG) Anaplastic Lymphoma Kinase (ALK) tyrosine kinase inhibitors (TKIs) in ALK + non-small cell lung cancer (NSCLC)
18 septembra, 2020 8:01 pm Leave your thoughtsAuthors: Tom Stinchcombe, Robert Charles Doebele, Xiaofei F. Wang, et. al. Abstract: 9027 Clinical Trial Registry Number: NCT02706626...
Brigatinib in pre-treated patients with ALK-positive advanced NSCLC
18 septembra, 2020 8:01 pm Leave your thoughtsAuthors: Renaud Descourt, Maurice Perol, Gaelle Rousseau-Bussac, et. al. Abstract: 9045 Citation: J Clin Oncol 37, 2019 (suppl;...
Pembrolizumab Increases Historic Survival Rate for Certain People with Advanced Non-Small Cell Lung Cancer
18 septembra, 2020 8:01 pm Leave your thoughtsJune 1, 2019 “These data are similar to what we have seen in other cancers treated with immunotherapy in that...
Karcinóm pľúc na ASCO© 2019
18 septembra, 2020 8:01 pm Leave your thoughtsÚvod Aj tento rok prinieslo ASCO© 2019 novinky v oblasti karcinómu pľúc v širokom spektre – od klinických štúdií, ktoré môžu zmeniť...
Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the first- and second-line treatment of unresectable mCRC
18 septembra, 2020 8:01 pm Leave your thoughtsAuthors: Chiara Cremolini, Carlotta Antoniotti, Sara Lonardi, et. al. Abstract: 3508 Clinical Trial Registry Number: NCT02339116 Citation:...
APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma
18 septembra, 2020 8:01 pm Leave your thoughtsAuthors: Margaret A. Tempero, Michele Reni, Hanno Riess, et. al. Abstract: 4000 Clinical Trial Registry Number: NCT01964430 ...